Literature DB >> 21612477

Bending the cost curve in cancer care.

Thomas J Smith1, Bruce E Hillner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21612477      PMCID： PMC4042405          DOI： 10.1056/NEJMsb1013826

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  58 in total

Review 1.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; David H Johnson; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; George R Simon; Scott J Swanson; Douglas E Wood; Stephen C Yang
Journal:  J Natl Compr Canc Netw       Date:  2010-07       Impact factor: 11.908

2.  How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement.

Authors:  Steven D Pearson; Peter B Bach
Journal:  Health Aff (Millwood)       Date:  2010-10       Impact factor: 6.301

3.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Authors:  Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George Demetri; Christopher E Desch; Philip A Pizzo; Charles A Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2006-05-08       Impact factor: 44.544

4.  Does reimbursement influence chemotherapy treatment for cancer patients?

Authors:  Mireille Jacobson; A James O'Malley; Craig C Earle; Juliana Pakes; Peter Gaccione; Joseph P Newhouse
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

5.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

6.  Giving honest information to patients with advanced cancer maintains hope.

Authors:  Thomas J Smith; Lindsay A Dow; Enid Virago; James Khatcheressian; Laurel J Lyckholm; Robin Matsuyama
Journal:  Oncology (Williston Park)       Date:  2010-05       Impact factor: 2.990

7.  Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives.

Authors:  Lindsay A Dow; Robin K Matsuyama; V Ramakrishnan; Laura Kuhn; Elizabeth B Lamont; Laurel Lyckholm; Thomas J Smith
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

8.  Impact of an inpatient palliative care team: a randomized control trial.

Authors:  Glenn Gade; Ingrid Venohr; Douglas Conner; Kathleen McGrady; Jeffrey Beane; Robert H Richardson; Marilyn P Williams; Marcia Liberson; Mark Blum; Richard Della Penna
Journal:  J Palliat Med       Date:  2008-03       Impact factor: 2.947

9.  Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

10.  Comparing hospice and nonhospice patient survival among patients who die within a three-year window.

Authors:  Stephen R Connor; Bruce Pyenson; Kathryn Fitch; Carol Spence; Kosuke Iwasaki
Journal:  J Pain Symptom Manage       Date:  2007-03       Impact factor: 3.612
View more
  113 in total

1.  Economic Analysis of a Three-Arm RCT Exploring the Delivery of Intensive, Prophylactic Swallowing Therapy to Patients with Head and Neck Cancer During (Chemo)Radiotherapy.

Authors:  Laurelie R Wall; Sanjeewa Kularatna; Elizabeth C Ward; Bena Cartmill; Anne J Hill; Elizabeth Isenring; Joshua Byrnes; Sandro V Porceddu
Journal:  Dysphagia       Date:  2018-12-04       Impact factor: 3.438

2.  Variation and consternation: access to unfunded cancer drugs in Canada.

Authors:  Scott R Berry; William K Evans; Elizabeth L Strevel; Chaim M Bell
Journal:  J Oncol Pract       Date:  2012-01       Impact factor: 3.840

3.  Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?

Authors:  Ethan Basch; Mark R Somerfield; Ann Partridge; Lowell Schnipper; Gary H Lyman
Journal:  J Oncol Pract       Date:  2011-10-18       Impact factor: 3.840

Review 4.  A way forward on the medically appropriate use of white cell growth factors.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

5.  Improving quality and addressing the rising costs of cancer care: two birds, one stone.

Authors:  Jason Luke; Joshua Mirkin; Peter Bach
Journal:  J Oncol Pract       Date:  2011-10-18       Impact factor: 3.840

6.  Finasteride and prostate cancer: a commentary.

Authors:  Channing J Paller; Thomas J Smith
Journal:  Oncologist       Date:  2012-06-20

Review 7.  Drug rechallenge and treatment beyond progression--implications for drug resistance.

Authors:  Elizabeth A Kuczynski; Daniel J Sargent; Axel Grothey; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2013-09-03       Impact factor: 66.675

Review 8.  Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review.

Authors:  Daniel M Geynisman; Chun-Ru Chien; Fabrice Smieliauskas; Chan Shen; Ya-Chen Tina Shih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Accuracy of Oncologists' Life-Expectancy Estimates Recalled by Their Advanced Cancer Patients: Correlates and Outcomes.

Authors:  Jason Lambden; Baohui Zhang; Robert Friedlander; Holly G Prigerson
Journal:  J Palliat Med       Date:  2016-08-30       Impact factor: 2.947

10.  End-of-life care of women with gynecologic malignancies: a pilot study.

Authors:  Nicole S Nevadunsky; Lori Spoozak; Sharon Gordon; Enid Rivera; Kimala Harris; Gary L Goldberg
Journal:  Int J Gynecol Cancer       Date:  2013-03       Impact factor: 3.437
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.